{"disease":{"id":"thalassemia-intermedia","name":"thalassemia intermedia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06831799","title":"ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT06931912","title":"Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia","phase":"NA","overall_status":"RECRUITING","enrollment_count":369,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06137079","title":"\"Iron Overload and Endocrinological Diseases\"","phase":"","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria di Modena","has_results":false},{"nct_id":"NCT01571635","title":"Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":46,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT04432623","title":"The BENeFiTS Trial in Beta Thalassemia Intermedia","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":36,"lead_sponsor_name":"Phoenicia BioScience","has_results":false},{"nct_id":"NCT04059406","title":"Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":29,"lead_sponsor_name":"Ionis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03993613","title":"Apotransferrin in Patients With β-thalassemia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Prothya Biosolutions","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}